USP22 and osteosarcoma: ALKBH5 upregulates the expression of USP22 and RNF40 by regulating the m6A levels of histones, leading to inhibition of H2A monoubiquitination and induction of critical oncogenes, ultimately promoting osteosarcoma progression [98].